Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07344168Not ApplicableNot Yet Recruiting

EndoArt® Implantation in Subjects With Chronic Corneal Edema - US Study

Role: lead

NCT05139771Not ApplicableCompleted

EndoArt® Implantation in Subjects With Chronic Corneal Edema

Role: lead

NCT03069521Not ApplicableCompleted

Study to Evaluate the Safety of the EndoArt™ for Treatment of Subjects Suffering From Corneal Edema

Role: lead

NCT03845374Not ApplicableCompleted

Prospective, Randomized Multi-Center Study of Using the Hyper-CL™ Lens in Subjects Suffering From Bacterial Keratitis

Role: lead

NCT01890252Not ApplicableCompleted

Hyper-CL™ Lens (Hyper Osmotic Contact Lens) In Subjects Suffering From Corneal Edema

Role: lead

NCT02660151Not ApplicableCompleted

Study of Using the Hyper-CL™ Lens (Hyper Osmotic Contact Lens) in Subjects Suffering From Corneal Edema

Role: lead

All 6 trials loaded